Nanoscope Advances Optogenetic Therapy for Retinal Diseases
Dallas, Texas, September 23, 2026 Nanoscope Therapeutics, Inc. announced plans to present new clinical data from its macular degeneration...
Apertura Gene Therapy
Advertisement
Apertura and Lexeo Advance Gene Therapy for Friedreich Ataxia
New York, New York, September 23, 2026 Apertura Gene Therapy announced that it will provide Lexeo Therapeutics with access...
Dassault Systèmes Powers Virtual Twin Factories with AI Agents
VELIZY-VILLACOUBLAY, France, July 23, 2026 Dassault Systèmes has expanded its 3DEXPERIENCE AI-native agentic platform with the launch of three...
Apertura Joins ARPA-H Program for Rare Gene Therapies
NEW YORK, N.Y., July 23, 2026 Apertura Gene Therapy has announced its participation in a consortium selected to receive...
Apertura Gene Therapy Advances NPC1 Gene Therapy Research
NEW YORK | July 9, 2026 Apertura Gene Therapy, a biotechnology company developing next-generation adeno-associated virus (AAV) capsids for...
Advertisement
